$2.98
arrow_drop_up0.63%Key Stats | |
---|---|
Open | $3.00 |
Prev. Close | $2.97 |
EPS | -2.56 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $24.70M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 2.90 | 3.00 |
52 Week Range | 2.00 | 3.83 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -2.56 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Lisata (LSTA) Stock Rallies More Than 30% YTD: Here's Why - Zacks Investment Research
Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial
Lisata Therapeutics to Participate in Upcoming June 2024 Industry and Investor Events
Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Lisata Therapeutics and Qilu Pharmaceutical Announce First Patient Treated in Qilu’s Phase 2 Trial in China of LSTA1 in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Lisata's (LSTA) LSTA1 Gets FDA Orphan Drug Tag for Osteosarcoma